Cholesterol meds to help smokers kick the habit

PRESS RELEASE FROM
NEUROPSYCHOPHARMACOLOGY

(http://www.nature.com/npp)

This press release is copyrighted to the journal Neuropsychopharmacology.
Its use is granted only for journalists and news media receiving it directly from the Nature Publishing Group.

Cholesterol meds to help smokers kick the habit
DOI: 10.1038/NPP.2012.31

Fibrate medications, currently used to treat high cholesterol and cardiovascular disease, may also help cigarette smokers quit, according to an animal study published this week in Neuropsychopharmacology. Since smoking is highly addictive and increases the risk of cardiovascular disease and mortality, normalizing lipids and reducing smoking could be a dual benefit of fibrate treatment. The fact that fibrates are already approved for human use should speed up clinical trials and the subsequent implementation of any treatment based on this work.
Tobacco-related disease is one of the major causes of premature death in the United States. Although smoking cessation treatments are available, they are not effective in many smokers. Steven Goldberg and colleagues are investigating the use of fibrate drugs to reduce the rewarding effects of nicotine in rats and squirrel monkeys. Fibrates are known to activate a hormone receptor that regulates energy and lipid metabolism and that has recently been implicated in regulating the behavioral effects of nicotine. The team found that administering a fibrate prevented nicotine addiction, decreased nicotine intake, and protected against relapses in the animals tested. It is yet to be determined whether these results are replicated in humans, however if they prove to be, this may be an effective way to treat tobacco addiction while reducing the smoking-associated risk of cardiovascular disease and mortality.


Author contact:
Steven Goldberg (National Institute on Drug Abuse, Baltimore, MD, USA)
Tel: +1 443 740 2519; E-mail: sgoldber@intra.nida.nih.gov

Editorial contact for Neuropsychopharmacology:
Natalie Marler (Neuropsychopharmacology, Brentwood, TN, USA)
Tel: +1 615 324 2371; E-mail: nmarler@acnp.org

 

Annual Meeting

Program CoverThe ACNP Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.

ACNP Publications

Program CoverThe College offers a variety of Publications with the latest and most comprehensive research in psychopharmacology and related fields.

Research Discussions

This forum enables discussion of articles that have appeared in Neuropsychopharmacology. It is intended to stimulate scholarly interactions among researchers, and to help educate members of the public who are interested in psychiatric illness.